Search clinical trials for: VSL#3 900 billion bacteria

Total 1279 results

Dayton Children's Hospital
National Institutes of Health (NIH)

Terminated

The Use of VSL#3 in Irritable Bowel Syndrome in Children (VSL#3)

Irritable Bowel Syndrome

United States
University of Maryland, Baltimore
National Center for Complementary and Integrative Health (NCCIH)

Terminated

Safety of VSL#3 in Adult Asthmatics

Asthma

United States
Policlinico Hospital

Unknown

Impact of Probiotic Preparation VSL#3 on Infants Colics

Infant Colics

Italy
Policlinico Hospital

Completed

Influence of Probiotic VSL#3 Administration on Metabolic and Immunological Profile of the Milk of Breastfeeding Mothers

Allergy

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Recruiting

VSL#3® vs Placebo in the Treatment of Fatigue and Other Symptoms in Long Covid (DELong#3) (DELong#3)

Long COVID

Italy
Bambino Gesù Hospital and Research Institute

Completed

Effects of VSL#3 on Metabolic, Endocrine, Lipidomic and Inflammatory Parameters of Pediatric Patients With BMI>90° (VAIIO)

Obesity

Italy
Beth Israel Deaconess Medical Center

Terminated

Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS

IBS

United States
Federico II University

Unknown

A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease

Crohn's Disease

Italy
Kaplan-Harzfeld Medical Center

Completed

Probiotics and Hospital Outcome in the Elderly (PROAGE)

Constipation | Diarrhea
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA) (PERMAJI)

Juvenile Idiopathic Arthritis

France
Catholic Health Initiatives

Terminated

Probiotics and Recovery From Surgery (PROGRESS)

Major Abdominal Operation

United States
University of North Carolina, Chapel Hill

Recruiting

Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis (HALT-IPF)

Idiopathic Pulmonary Fibrosis and Progressive Fibrotic Interstitial Lung Disease

United States
University of Michigan

Completed

Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC)

Hirschsprung Disease

United States
University of Dublin, Trinity College
Actial Farmaceutica S.r.l.

Unknown

Investigating the Effect of Dietary Supplement VSL#3 on Cognition and Mood in Healthy Older Adults

Alteration of Cognitive Function | Disturbance in Affect (Finding)

Ireland
Catholic University of the Sacred Heart

Unknown

VSL#3 Versus Placebo in Increasing the Pathological Major Response Rate in Patients With Rectal Cancer

Rectal Cancer

Italy
Elena Pita Calandre
Ferring Pharmaceuticals; Actial Farmaceutica S.r.l.

Completed

Probiotic VSL#3 for the Treatment of Gastrointestinal Symptoms Associated to Fibromyalgia

Fibromyalgia | Gastrointestinal Disease

Spain
Baylor College of Medicine
National Institute of Nursing Research (NINR); University of Washington

Completed

Safety Study of Probiotics in Adults With Irritable Bowel Syndrome

Irritable Bowel Syndrome

United States
Children's Mercy Hospital Kansas City
VSL Pharmaceuticals

Completed

Effect of VSL#3 on Intestinal Permeability in Pediatric Crohn's Disease

Crohn's Disease

United States
A.O. Ospedale Papa Giovanni XXIII
University of Padova

Unknown

ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study (ETOS)

Hepatic Encephalopathy

Italy
Virginia Commonwealth University
Bill and Melinda Gates Foundation

Completed

Pilot Study of Oral Probiotic Bacteria Supplementation to Reduce Chronic Immune Activation in HIV-infected Malian Women

HIV

Mali
TNO
NIZO Food Research; VSL Pharmaceuticals

Completed

Intestinal Barrier Function and Probiotics.

Inflammation | Intestinal Permeability | Challenge Test | Intestinal Health

Netherlands
Orphan Australia

Completed

VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease

Crohn's Disease

Australia
University College, London

Completed

The Clinical and Biological Effects Of The Use Of Probiotic VSL#3 In Patients With Oral Lichen Planus (CABRIO)

Oral Lichen Planus

United Kingdom
Samsung Medical Center

Unknown

The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's Disease

Crohn's Disease

Korea, Republic of
University of Utah
United States Department of Defense

Terminated

Probiotic (VSL #3) for Gulf War Illness

Gulf War Illness

United States
Hadassah Medical Organization

Unknown

VSL#3 Treatment in Children With Crohn's Disease

Crohn's Disease

Israel
Ashok Tuteja
United States Department of Defense

Unknown

Probiotic (Visbiome) for Gulf War Illness

Gulf War Illness

United States
VSL Pharmaceuticals

Terminated

The Effect of a Probiotic on Hepatic Steatosis

Fatty Liver

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Assess the Tolerability, Safety, Pharmacodynamics, and Pharmacokinetics of Ascending Single Doses (Including Food Interaction) and Ascending Multiple Doses of ACT-453859, and Multiple Doses of Setipiprant (ACT-129968)

Healthy
Nottingham University Hospitals NHS Trust
VSL Pharmaceuticals

Terminated

VSL#3 and Spontaneous Bacterial Peritonitis

Decompensated Cirrhosis | Ascites

United Kingdom
Northumbria University
Pronova BioPharma

Completed

The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood

Cognitive Function

United Kingdom
University of Alberta

Completed

The Effect of Probiotics (VSL) on Portal Hypertension

Portal Hypertension

Canada
UroGen Pharma Ltd.

Withdrawn

Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2") (INTIMO2)

Overactive Bladder

Israel
Northwell Health

Terminated

Effects of Probiotic on Inflammation and Microbiota in Patients With NASH (NASHPro)

Non-Alcoholic Fatty Liver Disease | Probiotics MeSH Descriptor Data 2018 | Interleukin-17 MeSH Descriptor Data 2018

United States
Chinese University of Hong Kong

Completed

Manipulation of Visceral Hypersensitivity With Probiotic Bacteria in Irritable Bowel Syndrome

Irritable Bowel Syndrome

Hong Kong
Charite University, Berlin, Germany

Completed

New E-Service for a Dietary Approach to the Elderly (RISTOMED)

Healthy | Aged

Germany
VSL Pharmaceuticals

Completed

Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative Colitis

Ulcerative Colitis

Italy
Azienda Policlinico Umberto I

Completed

Effects of VSL#3 on Neuro-cognitive Profile of HIV Patients

HIV Seropositivity | ART

Italy
University of Alberta
Canadian Institutes of Health Research (CIHR)

Completed

A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease.

Crohn's Disease | Inflammatory Bowel Disease

Canada
Global Alliance for TB Drug Development

Completed

A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults

Tuberculosis | Tuberculosis, Pulmonary

United States
BLIS Technologies Limited

Recruiting

Colonisation Efficacy of Oral Probiotic Fast Melt Powder

Microbial Colonization

New Zealand
Govind Ballabh Pant Hospital

Unknown

Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis (HE)

Hepatic Encephalopathy

India
Weill Medical College of Cornell University

Active, not recruiting

Trial to Compare Radiation Fibrosis With Five Versus Three Fractions

Malignant Neoplasm of Breast Stage I

United States
Trius Therapeutics LLC

Completed

Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections

Skin Diseases, Infectious | Skin Diseases, Bacterial

United States
MacroGenics

Completed

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

Cervical Cancer | Hematologic Neoplasms | Ovarian Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Small-cell Lung Cancer | TNBC - Triple-Negative Breast Cancer | HER2-positive Advanced Solid Tumors

Hong Kong, United States, Thailand, Australia, Spain, Bulgaria, Poland, Ukraine
University of Wisconsin, Madison

Suspended

Impact of Probiotics on Oral Microbiota in Older Adults With Dysphagia

Dysphagia

United States
Charles University, Czech Republic
University of Roma La Sapienza; University Of Perugia; Iscare i.v.f., Czech Republic and other collaborators

Active, not recruiting

The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease

Crohn Disease | Ulcerative Colitis

Czechia
Otsuka Pharmaceutical Development & Commercialization...
Bill and Melinda Gates Foundation

Completed

A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis

Pulmonary TB

South Africa
Sheba Medical Center

Terminated

The Long Term Effect of Adjustable Spaatz 3 Intragastric Balloon on Weight Loss

Hypertension | Obesity | Diabetes

Israel
Ardea Biosciences, Inc.

Completed

Single and Multiple Dose Study in Japanese Subjects

Gout

United States

Search clinical trials for: VSL#3 900 billion bacteria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations